3-[[1,3-Benzodioxol-5-ylmethyl-[2-(hydroxy-amino)-2-oxo-ethyl]-amino]-methyl]benzoic Acid

ID: ALA4215019

Chembl Id: CHEMBL4215019

PubChem CID: 132051441

Max Phase: Preclinical

Molecular Formula: C18H18N2O6

Molecular Weight: 358.35

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(CN(Cc1cccc(C(=O)O)c1)Cc1ccc2c(c1)OCO2)NO

Standard InChI:  InChI=1S/C18H18N2O6/c21-17(19-24)10-20(8-12-2-1-3-14(6-12)18(22)23)9-13-4-5-15-16(7-13)26-11-25-15/h1-7,24H,8-11H2,(H,19,21)(H,22,23)

Standard InChI Key:  KXEKYVROYPRQEX-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4215019

    ---

Associated Targets(Human)

MEP1B Tchem Meprin A subunit beta (94 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 358.35Molecular Weight (Monoisotopic): 358.1165AlogP: 1.62#Rotatable Bonds: 7
Polar Surface Area: 108.33Molecular Species: ACIDHBA: 6HBD: 3
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.65CX Basic pKa: 6.07CX LogP: -0.43CX LogD: -1.54
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.51Np Likeness Score: -0.71

References

1. Ramsbeck D, Hamann A, Richter G, Schlenzig D, Geissler S, Nykiel V, Cynis H, Schilling S, Buchholz M..  (2018)  Structure-Guided Design, Synthesis, and Characterization of Next-Generation Meprin β Inhibitors.,  61  (10): [PMID:29694039] [10.1021/acs.jmedchem.8b00330]

Source